InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+15.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by PERLMAN ANDREW J, Director. Officer active across 1 company, notably Arcus Biosciences, Inc.. Cumulatively, 6 filings have been logged. History available since 3 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
5,700 sharesCommon StockSEC:0001201617-26-000003:0
13,300 shares0Common StockSEC:0001724521-25-000092:0
8,400 shares0Common StockSEC:0001724521-24-000112:0
6,800 shares0Common StockSEC:0001209191-23-038148:0
4,100 shares0Common StockSEC:0001209191-22-037438:0
3,000 shares0Common StockSEC:0001209191-21-038635:0
6 of 6 declarations
About PERLMAN ANDREW J
Andrew J. Perlman serves as a Board Member at Arcus Biosciences, Inc. In this role, he is involved in overseeing the company's operations and in strategic decision-making. His experience in corporate governance helps guide the company towards its development goals.
